ATE285793T1 - Rhodaminderivate für die photodynamische diagnose und behandlung - Google Patents

Rhodaminderivate für die photodynamische diagnose und behandlung

Info

Publication number
ATE285793T1
ATE285793T1 AT00965683T AT00965683T ATE285793T1 AT E285793 T1 ATE285793 T1 AT E285793T1 AT 00965683 T AT00965683 T AT 00965683T AT 00965683 T AT00965683 T AT 00965683T AT E285793 T1 ATE285793 T1 AT E285793T1
Authority
AT
Austria
Prior art keywords
treatment
rhodamine derivatives
derivatives
photodynamic diagnosis
photodynamic
Prior art date
Application number
AT00965683T
Other languages
English (en)
Inventor
Denis-Claude Roy
Martin Guimond
Nestor A Molfino
Original Assignee
Univ Montreal
Hopital Maisonneuve Rosemont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Montreal, Hopital Maisonneuve Rosemont filed Critical Univ Montreal
Application granted granted Critical
Publication of ATE285793T1 publication Critical patent/ATE285793T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0023—Agression treatment or altering
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Transplantation (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT00965683T 1999-10-05 2000-10-03 Rhodaminderivate für die photodynamische diagnose und behandlung ATE285793T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15779099P 1999-10-05 1999-10-05
PCT/CA2000/001142 WO2001024824A1 (en) 1999-10-05 2000-10-03 Rhodamine derivatives for photodynamic diagnosis and treatment

Publications (1)

Publication Number Publication Date
ATE285793T1 true ATE285793T1 (de) 2005-01-15

Family

ID=22565296

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00965683T ATE285793T1 (de) 1999-10-05 2000-10-03 Rhodaminderivate für die photodynamische diagnose und behandlung

Country Status (12)

Country Link
EP (1) EP1267931B1 (de)
JP (3) JP4859319B2 (de)
KR (1) KR100697400B1 (de)
AT (1) ATE285793T1 (de)
AU (1) AU781855B2 (de)
BR (1) BR0014135A (de)
CA (2) CA2699662A1 (de)
DE (1) DE60017201T2 (de)
ES (1) ES2234668T3 (de)
MX (1) MXPA02003522A (de)
PT (1) PT1267931E (de)
WO (1) WO2001024824A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8409564B2 (en) 1999-10-05 2013-04-02 Universite De Montreal Rhodamine derivatives for photodynamic diagnosis and treatment
JP4647187B2 (ja) * 2001-04-02 2011-03-09 セルメド バイオサイエンシズ インコーポレイテッド ハロゲン化ローダミン誘導体およびその適用
CA2342675A1 (en) 2001-04-02 2002-10-02 Abdelkrim Habi Halogenated rhodamine derivatives and applications thereof
BR0214571A (pt) * 2001-11-29 2006-05-30 Therakos Inc métodos para pré-tratar um indivìduo com fotoférese extracorporal e/ou células apoptóticas
MXPA06006286A (es) * 2003-12-05 2006-09-04 Univ Montreal Compuestos inmunologicos para prevencion, proteccion, profilaxis o tratamiento de trastornos inmunologicos, infecciones y cancer.
GB0912584D0 (en) * 2009-07-20 2009-08-26 Ucl Business Plc Cyclosporin conjugates
EP3058957A1 (de) 2015-02-19 2016-08-24 Kiadis Pharma Intellectual Property BV Verbessertes fotodynamisches Verfahren und daraus hergestelltes Produkt
RU2637279C2 (ru) * 2015-12-25 2017-12-01 Сергей Петрович Кречетов Способ фотодинамической терапии
TWI715927B (zh) * 2019-02-01 2021-01-11 國立清華大學 組合物用於製備治療癌細胞的藥物的用途
EP3730627A1 (de) 2019-04-25 2020-10-28 Kiadis Pharma Intellectual Property BV Verfahren zur überprüfung der spenderidentität
EP3769770A1 (de) 2019-07-23 2021-01-27 Kiadis Pharma Intellectual Property BV Verfahren zur hemmung oder prävention von infektionen bei einem transplantatempfänger
CN115960090B (zh) * 2022-12-30 2024-03-29 中山大学 一种罗丹明b修饰吡啶配体的制备方法及其光催化抗菌应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321919A (en) * 1979-12-11 1982-03-30 Leukocyte Research, Inc. Method and system for externally treating human blood
EP0544895B1 (de) * 1991-06-21 1997-08-27 Baxter International Inc. Verfahren zur inaktivierung von pathogenen in einer körperflüssigkeit
US5807881A (en) * 1992-05-27 1998-09-15 Quadra Logic Technologies, Inc. Method for selectively reducing activated leukocyte cell population
US5556992A (en) * 1994-09-02 1996-09-17 Universite De Montreal Novel rhodamine derivatives for photodynamic therapy of cancer and in vitro purging of the leukemias
DE69733826T2 (de) * 1996-03-29 2006-05-24 Therakos, Inc. Behandlung von leukocyten durch photopheresis
WO1998019677A1 (fr) * 1996-11-06 1998-05-14 Meiji Seika Kaisha, Ltd. Traitement de maladies auto-immunes par photochimiotherapie
EP1005531A2 (de) * 1997-07-21 2000-06-07 Cerus Corporation Verfahren zur verhandlung für leukozyten, leukozyten enthaltende zusammensetzungen und deren verwendungen
EP1010426A4 (de) * 1997-08-05 2004-06-30 Meiji Seika Kaisha Immunosuppresion durch photochemotherapie
EP1034288A4 (de) * 1997-12-04 2002-11-27 Univ Duke Methoden zur isolierung und verwendung von cd7+cd34-lin-hämatopoetischen zellen

Also Published As

Publication number Publication date
WO2001024824A1 (en) 2001-04-12
CA2382885A1 (en) 2001-04-12
AU781855B2 (en) 2005-06-16
BR0014135A (pt) 2002-05-21
KR100697400B1 (ko) 2007-03-20
MXPA02003522A (es) 2004-09-10
JP2011093939A (ja) 2011-05-12
JP5476342B2 (ja) 2014-04-23
JP2011229537A (ja) 2011-11-17
ES2234668T3 (es) 2005-07-01
PT1267931E (pt) 2005-05-31
DE60017201T2 (de) 2005-12-29
JP2003510372A (ja) 2003-03-18
DE60017201D1 (de) 2005-02-03
EP1267931B1 (de) 2004-12-29
CA2699662A1 (en) 2001-04-12
JP4859319B2 (ja) 2012-01-25
KR20020050234A (ko) 2002-06-26
EP1267931A1 (de) 2003-01-02
AU7635700A (en) 2001-05-10
CA2382885C (en) 2010-06-29

Similar Documents

Publication Publication Date Title
ATE285793T1 (de) Rhodaminderivate für die photodynamische diagnose und behandlung
HUP0000576A2 (hu) A zöld porfirinek alkalmazása szekunder szürkehályogok kezelésére alkalmas gyógyszerek készítésében
SE9902163D0 (sv) Stable rotable radiation gantry
NO20075065L (no) Anvendelse av isoflavonforbindelser til a behandle hjertesykdom
DE69718053D1 (de) in vitro methoden und verwendung von pharmazeutische zusammensetzungen für die BEHANDLUNG VON INNENOHRHAARZELLEN
ES2191192T3 (es) Tienopirimidinas.
WO2003032901A3 (en) Pathological tissue detection and treatment employing targeted benzoindole optical agents
GR1000611B (el) Μεθοδος για την παρασκευη οφθαλμικων συνθεσεων κυκλοσπορινης.
ATE288431T1 (de) Substituierte bizyklische derivate für die behandlung von unnormalem zellwachstum
NZ529682A (en) Biologically active methylene blue derivatives
ES2150157T3 (es) Piridinas 2-aril sustituidas.
ATE250576T1 (de) Substituierte pyrrolylverbindungen zur behandlung von entzündungen
PA8447801A1 (es) Derivados del acido hexanoico
DE60022754D1 (de) Diagnose und behandlung von arrhythmien
TR200402628T4 (tr) Androjenetik ve yaygın alopezinin tedavisinde melatonin maddesinin kullanımı
CA2339384A1 (en) Improved method for targeted topical treatment of disease
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
DE60001555D1 (de) Wässrige lösung zum konservieren von gewebe und organen
WO2001024825A3 (en) Significance of dosimetry in photodynamic therapy of injured arteries
BR0017163A (pt) Derivados 5-hidróxi-indazol para tratamento do glaucoma
TR200101149T2 (tr) Dış retina bozukluklarının tedavisi.
DE69003937D1 (de) Mittel für die diagnose und die behandlung der melanomen, halogenierte, aromatische derivate, verwendbar als solche mittel und ihre herstellung.
MX9700959A (es) Derivados de becimidazol que tienen actividad dopaminergica.
WO2000061124A3 (en) Use off cell membrane penetrating indigoid bisindole derivatives
CY1106409T1 (el) Παραγωγα κινολινης

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1267931

Country of ref document: EP